Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 8, 1998, Pages 891-898

  Kawasaki Yatsugi, Sachiko ^a   Shimizu Sasamata, Masao ^a   Yatsugi, Shin Ichi ^a   Yamaguchi, Tokio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; APTIGANEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NONHUMAN; RAT; STROKE;

EID: 0031706167     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb04005.x     Document Type: Article

References (44)

1. Aronowski, J., Ostrow, P., Samways, E., Strong, R., Zivin, J. A., Grotta, J. C. (1994) Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats. Stroke 25: 2235-2240
2. Benveniste, H., Drejer, J., Schousboe, A., Diemer, N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43: 1369-1374
3. Boast, C. A., Gerhardt, S. C., Pastor, G., Lehmann, J., Etienne, P. E., Liebman, J. M. (1988) The N-methyl-D-aspartate antagonists CGS19755 and CPP reduce ischemic brain damage in gerbils. Brain Res. 442: 345-348
4. Buchan, A., Pulsinelli, W. A. (1990) Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10: 311-316
5. Buchan, A., Li, H., Pulsinelli, W. A. (1991) The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci. 11: 1049-1056
6. Cohen, R. A., Hasegawa, Y., Fischer, M. (1994) Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by EEG and infarct volume. Neurol. Res. 16: 443-448
7. Duverger, D., Mackenzie, E. T. (1988) The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial blood pressure, blood glucose concentration and age. J. Cereb. Blood Flow Metab. 8: 449-461
8. Freund, T. F., Buzsaki, G., Leon, A., Somogyi, P. (1990) Hippocampal cell death following ischemia: effects of brain temperature and anesthesia. Exp. Neurol. 108: 251-260
9. Gill, R. (1994) The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and the role in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 6: 225-256
10. Gill, R., Nordhorm, L., Lodge, D. (1992): The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brain Res. 580: 35-43
11. Ginsberg, M. D., Busto, R. (1989) Rodent models of cerebral ischemia. Stroke 20: 1627-1642
12. Graham, S. H., Chen, J., Lan, J. Q., Simon, R. P. (1996) A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. J. Pharmacol. Exp. Ther. 276: 1-4
13. Hasegawa, Y., Latour, L. L., Sotak, C. H., Dardzinski, B., Fisher, M. (1994) Temperature-dependent change of apparent diffusion coefficient of water in normal and ischemic brain in rats. J. Cereb. Blood Flow Metab. 14: 383-390
14. Hatfield, R. H., Gill, R., Brazell, C. (1992) The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model. Eur. J. Pharmacol. 216: 1-7
15. Hayward, N. J., McKnight, A. T., Woodruff, G. N. (1993) Brain temperature and the neuroprotective action of enadoline and dizocilpine in the gerbil model of global ischemia. Eur. J. Pharmacol. 236: 247-253
16. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851-853
17. Izumisawa, N., Kawakami, A., Ohata, T., Hanada, T., Okeda, R. (1995) YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats. Exp. Neurol. 134: 199-204
18. Kawasaki-Yatsugi, S., Yatsugi, S., Koshiya, K., Shimizu-Sasamata, M. (1997) Neuroprotective effect of YM90K, an AMPA receptor antagonist, against delayed neuronal death induced by transient global ischemia in gerbils and rats. Jpn J. Pharmacol. 74: 253-260
19. Knapp, A. G., Mathews, L. I., Gamzu, E. R. (1997) Clinical experience with the NMDA ion-channel blocker, antiganel hydrochloride (Cerestat). In: Herrling, P. (ed.) Excitatory Amino Acids - Clinical Results with Antagonists. Academic Press, San Diego, pp 31-42
20. Koek, W., Woods, J. H., Winger, G. D. (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245: 969-974
21. König, J. F. R., Klippel, R. A. (1963) The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the I Brain Stem. Krieger, New York
22. Margaill, I., Parmentier, S., Callebert, J., Allix, M., Boulu, R. G., Plotkine, M. (1996) Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. J. Cereb. Blood Flow Metab. 16: 107-113
23. Meadows, M.-E., Fisher, M., Minematsu, K. (1994) Delayed treatment with a noncompetitive NMDA antagonist, CNS-1102, reduces infarct size in rats. Cerebrovasc. Dis. 4: 26-31
24. 2+ homeostasis. Prog. Neurobiol. 37: 255-285
25. Minematsu, K., Fisher, M., Li, L., Davis, M. A., Knapp, A. G., Cotter, R. E., McBurney, R. N., Sotak, C. H. (1993a) Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weight MRI. Neurology 43: 397-403
26. Minematsu, K., Fisher, M., Li, L., Sotak, C. H. (1993b) Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspattate antagonist and reperfusion in experimental stroke in rats. Stroke 24: 2074-2081
27. Ohmori, J., Sakamoto, S., Kubota, H., Shimizu-Sasamata, M., Okada, M., Kawasaki, S., Hidaka, K., Togami, J., Furuya, T., Murase, K. (1994) 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem. 37: 467-475
28. Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., Sesma, M. A. (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254: 1515-1518
29. Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M., McCulloch, J. (1988) The glutamate antagonist MK801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551
30. Reddy, N. L., Hu, L. Y., Cotter, R. F., Fischer, J. B., Wong, W. J., McBurney, R. N., Weber, E., Holmes, D. L., Wong, S. T., Prasad, R., Keana, J. F. W. (1994) Synthesis and structure-activity studies of N,N′-diarylguanidine derivatives. N-(1-naphtyl)-N′-(3-ethylphenyl)-N′-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist. J. Med. Chem. 37: 260-267
31. Sauer, D., Weber, E., Luond. G., Silva, F. D., Allegrini, P. R. (1995) The competitive NMDA antagonist CGP 40116 permanently reduces brain damage after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 15: 602-610
32. Sheardown, M. J., Nielsen, E. Ø, Hansen, A. J., Jacobsen, P., Honore, T. (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571-574
33. Shimizu-Sasamata, M., Kawasaki-Yatsugi, S., Okada, M., Sakamoto, S., Yatsugi, S., Togami, J., Hatanaka, K., Ohmori, J., Koshiya, K., Usuda, S., Murase, K. (1996) YM90K: Pharmacological characterization as a selective and potent α-amino-3,5-methylisoxazole-4-propionate (AMPA)/kainate receptor antagonist. J. Pharmacol. Exp. Ther. 276: 84-92
34. Siesjö, B. K. (1981) Cell damage in the brain: aspeculative synthesis. J. Cereb. Blood Flow Metab. 1: 155-185
35. Siesjö, B. K., Bengtsson, F. (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9: 127-140
36. Simon, R., Swan, J., Griffith, T., Meldrum, B. (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850-852
37. Smith, S. E., Merdrum, B. J. (1992) Cerebroprotectiveeffect of a non-N-methyl-D-aspartate antagonist, GYKI52466, after focal ischemia in the rat. Stroke 23: 861-864
38. Sugiyama, H., Ito, I., Hirono, C. (1987) A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature 325: 531-533
39. Tamura, A., Graham, D. I., McCulloch, J., Teasdale, G. M. (1981) Focal cerebral ischemia in the rat: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1: 53-60
40. Verdoorn, T. A., Burnashev, N., Monyer, H., Seeburg, P. H., Sakmann, B. (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252: 1715-1718
41. Wong, L. A., Kemp, J. A. (1991) Site for antagonism of the N-methyl-D-aspartate receptor channel complex. Annu. Rev. Pharmacol. Toxicol. 31: 401-425
42. Xue, D., Huang, Z. G., Barnes, K., Lesiuk, H. J., Smith, K. E., Buchan, A. M. (1994) Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14: 251-261
43. Yao, H., Ibatashi, S., Nakane, H., Cai, H., Uchimura, H., Fujishima, M. (1997) AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Brain Res. 753: 80-85
44. Yatsugi, S., Takahashi, M., Kawasaki-Yatsugi, S., Koshiya, K., Sakamoto, S., Uematsu, D., Shimizu-Sasamata, M. (1996) Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal ischemia in cats. J. Cereb. Blood Flow Metab. 16: 959-966